4.6 Article

Obesity and the lung: 3 . Obesity, respiration and intensive care

Journal

THORAX
Volume 63, Issue 10, Pages 925-931

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/thx.2007.086835

Keywords

-

Funding

  1. National Institutes of Health [RO1-HL73146, SCOR P50 HL060292, AG024837]
  2. American Heart Association
  3. Respironics
  4. Cephalon
  5. Restore Medical
  6. Apnex Medical
  7. Itamar Medical
  8. Novartis
  9. Inspiration Medical
  10. NMT Medical and Pfizer
  11. National Health and Medical Research Council
  12. Australian Research Council Discovery Grant
  13. ResMed and Inspiration Medical

Ask authors/readers for more resources

Obesity is a major problem from a public health perspective and a difficult practical matter for intensivists. The obesity pandemic has required treating clinicians to develop an appreciation of the substantial pathophysiological effects of obesity on the various organ systems. The important physiological concepts are illustrated by focusing on obstructive sleep apnoea, obesity hypoventilation syndrome, abdominal compartment syndrome and ventilatory management of the obese patient with acute respiratory distress syndrome.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available